Biofrontera Inc.
BFRI
$0.72
-$0.0674-8.56%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 75.37% | -2,105.84% | 97.54% | -396.00% | 155.60% |
| Total Depreciation and Amortization | -29.17% | 0.97% | 0.65% | 4.07% | 17.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -95.02% | 119.65% | -222.14% | 156.28% | -435.09% |
| Change in Net Operating Assets | -96.56% | 819.30% | -86.94% | 149.89% | -381.09% |
| Cash from Operations | 15.81% | 74.41% | -41.95% | 62.50% | -342.42% |
| Capital Expenditure | -- | -100.00% | 184.21% | -733.33% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | -187.72% | -10.94% | -83.25% |
| Cash from Investing | -- | 100.00% | -- | -100.00% | -80.89% |
| Total Debt Issued | -- | -- | -- | -- | 49.15% |
| Total Debt Repaid | 100.00% | 86.17% | -15.62% | 80.38% | -30.88% |
| Issuance of Common Stock | -- | -100.00% | -2.92% | 70.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,459.06% | -105.64% | -8.88% | -13.63% | 1,036.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 301.33% | -367.97% | -77.28% | 219.00% | -101.65% |
